Drugs / Capsulized fecal microbiota transfer
Capsulized fecal microbiota transfer
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06192693 | Jan 2024 → Feb 2029 expected | type 2 diabetes mellitus | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Capsulized fecal microbiota transfer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06192693 ↗ |
| Modality | Other / unclassified | “oral capsulized FMT” NCT06192693 ↗ |
| Route | Oral | “Recent technologic developments enabled to generate oral capsulized FMT” NCT06192693 ↗ |